Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology.

Related Articles

Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology.

Curr Top Med Chem. 2016 Feb 15;

Authors: Vadakkan MV, Vinod Kumar GS

Abstract
Dry powder inhalers (DPI) attracted the attention of pharmaceutical field due to its enlarging market share in inhalable formulations. These formulations also pose patient compliance and good shelf life. Earlier DPI formulations were intended for local effect in lung (asthma and chronic obstructive pulmonary diseases), whereas 21st century witnessed formulations intended for systemic effect too. A better understanding of physiology of lung and fluidics of air flow helped in targeting alveoli using DPI technology. Modern characterization tools also accelerated the research pace. In addition to the synthetic molecules, DPI also was proved to be a better system for delivering biological molecules including vaccines. This review includes the mechanisms of drug deposition, advancements in the fields of DPI devices, various characterization tools and particle engineering. In this review we have related the chronological advancement of inhalational technology starting from 1788 AD to the present.

PMID: 26876523 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

World Allergy Congress Presents Scientific Advancements in Allergy, Asthma … – PR Web (press release)


PR Web (press release)

World Allergy Congress Presents Scientific Advancements in Allergy, Asthma
PR Web (press release)
Allergic diseases and asthma are increasing worldwide, affecting as much as 30% of the world's population. New research and international expert consensus recommendations will be presented that will impact on the future management of these globally

and more »

View full post on asthma – Google News

Treatment, Medicine Advancements Need Clinical Trial Subjects – Wheeling Intelligencer

Treatment, Medicine Advancements Need Clinical Trial Subjects
Wheeling Intelligencer
vice president for the Pharmaceutical Research and Manufacturers of America, said there are 210 clinical trials throughout the state for six of the most harmful diseases: cancer, diabetes, heart disease, mental illness, stroke and asthma.
New cancer drugParkersburg News

all 3 news articles »

View full post on asthma – Google News